De Backer Marianne
Vir Biotechnology, Inc. · President and CEO
De Backer Marianne is listed in filings as President and CEO at Vir Biotechnology, Inc.. This profile follows SEC Form 4 activity through Apr 30, 2026, including sale activity. Recent filings connect the profile to Vir Biotechnology, Inc. (VIR). The current snapshot covers public activity from Jun 12, 2024 to Apr 30, 2026. Reported amounts are shown as $664.4K to $141.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $141k14.8k shares | SellFeb 24, 2026 | $9.53 | $9.40 | |
| $142k19k shares | SellFeb 23, 2026 | $7.45 | $9.40 | |
| $474k79.7k shares | SellApr 3, 2025 | $5.95 | $9.40 | |
| $152k16.1k shares | SellFeb 24, 2025 | $9.45 | $9.40 |